Literature DB >> 7096920

Nomifensine-induced pregnancy in a hyperprolactinemic woman.

A R Genazzani, V De Leo, F Camanni, E E Müller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7096920     DOI： 10.1007/BF03350505

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  7 in total

1.  A new pharmacological approach to the diagnosis of hyperprolactinaemic states: the nomifensine test.

Authors:  A R Genazzani; F Camanni; F Massara; E Picciolini; D Cocchi; L Belforte; E E Müller
Journal:  Acta Endocrinol (Copenh)       Date:  1980-02

Review 2.  Dopamine-mimetic and antagonist drugs: diagnostic and therapeutic applications in endocrine disorders.

Authors:  E E Müller; F Camanni; A R Genazzani; F Casanueva; D Cocchi; V Locatelli; F Massarå; P Mantegazza
Journal:  Life Sci       Date:  1981-08-31       Impact factor: 5.037

3.  The management of prolactin-secreting pituitary tumors.

Authors:  S R George; G N Burrow
Journal:  J Endocrinol Invest       Date:  1981 Oct-Dec       Impact factor: 4.256

4.  Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors.

Authors:  S A Fine; L A Frohman
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

5.  Prolactin-releasing effect of domperidone in normoprolactinemic and hyperprolactinemic subjects.

Authors:  F Camanni; A R Genazzani; F Massara; R La Rosa; D Cocchi; E E Müller
Journal:  Neuroendocrinology       Date:  1980       Impact factor: 4.914

6.  Effect of central nervous system dopaminergic activation on prolactin secretion in man: evidence for a common central defect in hyperprolactinemic patients with and without radiological signs of pituitary tumors.

Authors:  P G Crosignani; C Ferrari; A Malinverni; C Barbieri; A M Mattei; R Caldara; M Rocchetti
Journal:  J Clin Endocrinol Metab       Date:  1980-11       Impact factor: 5.958

7.  Nomifensine: diagnostic test in hyperprolactinemic states.

Authors:  E E Müller; A R Genazzani; S Murru
Journal:  J Clin Endocrinol Metab       Date:  1978-12       Impact factor: 5.958
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.